BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31794500)

  • 1. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
    Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
    Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
    Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional CO
    Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
    Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.
    Samuels JB; Garcia MA
    Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
    Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How I do? a treatment with fractional CO
    Jardin I; Louis-Vahdat C; Canlorbe G; Mergui JL; Uzan C; Azaïs H
    Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):735-739. PubMed ID: 30266539
    [No Abstract]   [Full Text] [Related]  

  • 10. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
    Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G
    Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety evaluation of fractional CO
    Di Donato V; D'Oria O; Scudo M; Prata G; Fischetti M; Lecce F; Schiavi MC; Giannini A; Muzii L; Battaglia F; Monti M; Benedetti Panici P
    Maturitas; 2020 May; 135():34-39. PubMed ID: 32252962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy.
    Sokol ER; Karram MM
    Menopause; 2016 Oct; 23(10):1102-7. PubMed ID: 27404032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CO
    Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
    Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
    Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
    Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of fractional CO
    Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H
    Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of CO
    Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D
    Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study.
    Palma F; Volpe A; Villa P; Cagnacci A;
    Maturitas; 2016 Jan; 83():40-4. PubMed ID: 26421474
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.